The settlement resolves all claims related to a breach-of-contract arbitration initiated by the virtual care company in 2022, according to an SEC filing reviewed by Becker’s.
The dispute centered on Walgreens’ decision to in-source certain services previously provided by Everly Health Solutions, including test ordering and oversight, without consulting the company. Everly also alleged fraudulent inducement and misappropriation of branding.
This settlement follows a Delaware federal court ruling that upheld a $988 million arbitration award in Everly Health Solutions’ favor, rejecting Walgreens’ argument that the damages should have been capped at $79 million under the contract.
